A SYSTEMS PHARMACOLOGY MODEL TO EVALUATE TRIPLE DRUG COMBINATION THERAPY AT OVERCOMING RESISTANCE TO ANTI-HER2 THERAPY IN HER2-POSITIVE BREAST CANCER.

被引：0
|
作者：
Franco, Y. [1 ]
Ramakrishnan, V. [2 ]
Vaidya, T. [1 ,3 ]
Ait-Oudhia, S. [1 ]
机构：
[1] Univ Florida, Orlando, FL USA
[2] Univ Buffalo, Buffalo, NY USA
[3] Boehringer Ingelheim Pharmaceut, Ridgefield, CT USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PIII-120
引用
收藏
页码：S111 / S111
页数：1
相关论文
共 50 条
  • [1] Targeting the mevalonate pathway in HER2-positive breast cancer to overcome resistance to anti-HER2 therapy
    Sethunath, Vidyalakshmi
    Hu, Huizhong
    De Angelis, Carmine
    Veeraraghavan, Jamunarani
    Qin, Lanfang
    Rimawi, Motthaffar F.
    Osborne, Kent C.
    Schiff, Rachel
    [J]. CANCER RESEARCH, 2018, 78 (04)
  • [2] Overcoming trastuzumab resistance in HER2-positive breast cancer using combination therapy
    Derakhshani, Afshin
    Rezaei, Zohreh
    Safarpour, Hossein
    Sabri, Morteza
    Mir, Atefeh
    Sanati, Mohammad Amin
    Vahidian, Fatemeh
    Moghadam, Ali Gholamiyan
    Aghadoukht, Ali
    Hajiasgharzadeh, Khalil
    Baradaran, Behzad
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (04) : 3142 - 3156
  • [3] Anti-HER2 therapy for HER2-positive metastatic breast cancer: regimens and treatment outcomes
    Watanabe, Kenichi
    Hagio, Kanako
    Baba, Motoi
    Ikarashi, Mayuko
    Sato, Masako
    Tomioka, Nobumoto
    Takahashi, Masato
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 143 - 143
  • [4] RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer
    Sanz-Moreno, Adrian
    Palomeras, Sonia
    Pedersen, Kim
    Morancho, Beatriz
    Pascual, Tomas
    Galvan, Patricia
    Benitez, Sandra
    Gomez-Miragaya, Jorge
    Ciscar, Marina
    Jimenez, Maria
    Pernas, Sonia
    Petit, Anna
    Soler-Monso, Maria Teresa
    Vinas, Gemma
    Alsaleem, Mansour
    Rakha, Emad A.
    Green, Andrew R.
    Santamaria, Patricia G.
    Mulder, Celine
    Lemeer, Simone
    Arribas, Joaquin
    Prat, Aleix
    Puig, Teresa
    Gonzalez-Suarez, Eva
    [J]. BREAST CANCER RESEARCH, 2021, 23 (01)
  • [5] RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer
    Adrián Sanz-Moreno
    Sonia Palomeras
    Kim Pedersen
    Beatriz Morancho
    Tomas Pascual
    Patricia Galván
    Sandra Benítez
    Jorge Gomez-Miragaya
    Marina Ciscar
    Maria Jimenez
    Sonia Pernas
    Anna Petit
    María Teresa Soler-Monsó
    Gemma Viñas
    Mansour Alsaleem
    Emad A. Rakha
    Andrew R. Green
    Patricia G. Santamaria
    Celine Mulder
    Simone Lemeer
    Joaquin Arribas
    Aleix Prat
    Teresa Puig
    Eva Gonzalez-Suarez
    [J]. Breast Cancer Research, 23
  • [6] Determining the Factors Predicting the Response to Anti-HER2 Therapy in HER2-Positive Breast Cancer Patients
    You, Ji Young
    Park, Kyoung Hwa
    Lee, Eun Sook
    Kwon, Youngmee
    Kim, Kyoung Tae
    Nam, Seungyoon
    Kim, Dong Hee
    Bae, Jeoung Won
    [J]. CANCER CONTROL, 2023, 30
  • [7] The perspective of anti-HER2 therapy for HER2 positive breast cancer
    Iwata, Hiroji
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 11 - 11
  • [8] Determining the Factors Predicting the Response to Anti-HER2 Therapy in HER2-Positive Breast Cancer Patients
    You, Ji Young
    Park, Kyoung Hwa
    Lee, Eun Sook
    Kwon, Youngmee
    Kim, Kyoung Tae
    Nam, Seungyoon
    Kim, Dong Hee
    Bae, Jeoung Won
    [J]. CANCER CONTROL, 2022, 29
  • [9] De novo resistance biomarkers to anti-HER2 therapies in HER2-positive breast cancer
    Madrid-Paredes, Adela
    Canadas-Garre, Marisa
    Sanchez-Pozo, Antonio
    Angel Calleja-Hernandez, Miguel
    [J]. PHARMACOGENOMICS, 2015, 16 (12) : 1411 - 1426
  • [10] Anti-HER2 antibody therapy using gene-transduced adipocytes for HER2-positive breast cancer
    Takahito Masuda
    Hiroshi Fujimoto
    Ryotaro Teranaka
    Masayuki Kuroda
    Yasuyuki Aoyagi
    Takeshi Nagashima
    Takafumi Sangai
    Mamoru Takada
    Ayako Nakagawa
    Yoshitaka Kubota
    Koutaro Yokote
    Masayuki Ohtsuka
    [J]. Breast Cancer Research and Treatment, 2020, 180 : 625 - 634
12345